WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, a registered investment adviser, initiated a new position in Merck & Co., Inc. (NYSE:MRK) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 1,797,434 shares of the Healthcare company, valued at approximately $196,035,842 as of the filing date.
Merck & Co., Inc.'s stock currently trades at $112.08 with a market capitalization of $248,844,966,737.
